Supply Chain

The big news in the doctor world during the past few weeks has been the new guidelines for statin medications. The pharmaceutical companies have expanded the definition of disease to label more people as diseased.

Global spending on medicines is predicted to grow slowly in the next five years, with growth in developed countries much slower than in emerging markets.

For years, hospitals have been trying to discover new strategies for getting greater efficiencies out of their supply chains. Here are some current trends.

This blog post was removed at the request of the author. Please see his other blogs here: http://www.healthcarefinancenews.com/blog/author/2326.

Medical device maker Stryker Corp. will pay $13.3 million to the Securities and Exchange Commission to settle civil charges that the company bribed physicians, healthcare professionals and government officials to obtain or keep business in five countries.

America has a major drug problem, but it's not the one that probably comes immediately to mind. It is a continual and rotating shortage of important drugs.

As Republicans and Democrats have battled over reopening the federal government and raising the federal debt ceiling, one idea that keeps coming up is a repeal of the 2010 health law's tax on medical devices.

Florida's Baptist Health has devised a more efficient way to manage their medical devices and share risk, and it's helping them place real controls on capital costs.

With all of the energy around meaningful use, ICD-10, HIE, accountable care, Medicare reimbursements, and other changes and trends within healthcare, it is likely that you are busier than ever.

With penalties to pharma companies for violating the Physician Payments Sunshine Act potentially ranging into the millions of dollars, adhering to the act is a priority. But when it comes to marketing materials, achieving compliance is not simple.